Immunology PhD. Biotech/Pharma Specialist. Investor/Public markets. Keeping drug dev honest
Athens
Joined January 2019
- Tweets2.8K
- Following215
- Followers334
- Likes9.1K
Noone could've seen the iceberg that sunk $SAVA
I guess $SAVA Remi was right "Biomarkers don't lie". But your wife and her lackey do! Good riddance
Enea Milioris retweeted
Another Expression of Concern for a Cassava Sciences $SAVA paper. First commented on by @Adrian_H in September 2023, now flagged by @FrontiersIn Aging.
pubpeer.com/publications/B42…
frontiersin.org/journals/agi…
Enea Milioris retweeted
This one is for all the $sava dopes who end their pump tweets with #Alzheimers #endalz etc.. Cure Alzheimer’s Fund thinks YOU are part of the problem, congrats 🥳
Cure Alzheimer's Fund, a non-profit that has contributed over 207m USD to fund Alzheimer's research, published an utterly scathing takedown of Cassava Sciences $SAVA
curealz.org/news-and-events/…
Enea Milioris retweeted
“One of the things we did a number of years ago was have an independent laboratory, Quanterix.. I want to remind you of this.. Quanterix did an assessment of a biomarker called pTau-181 which was in vogue then, and did show a significant.. statistically significant change.. it was a small number of subjects, a double-blind study looking at placebo vs two doses of drug, and it was in fact, significant, and I just want to remind you of that.” -- Rick Barry, August 8 2024
cassavasciences.com/events/e…
$SAVA
$SAVA "drops defamation suit against short-sellers after researcher charged"
$SAVA Cassava - a public company - promises to communicate material news - yes, even the bad ones! - going forward.. 🙈🙈🙈
(wtf did I just read)
$SAVA 1st pics of Lindsay & Remi Barbier explaining to their cult why they'll have to forget about retirement
Enea Milioris retweeted
$SAVA With resignations of top leaders, Cassava Sciences exposes a dark, ugly corner of the Alzheimer’s disease world statnews.com/2024/07/17/cass…
Happy Retirement Remi & Lindsay!!!
$SAVA 🎉💐🙏😜
Important news out of Cassava Science, maker of the controversial experimental Alzheimer's drug simufilam - two top leaders Barbier and Burns suddenly resign cassavasciences.com/news-rel…
When fundraising for a serial fraudster facing criminal charges it's important to move the goalposts $SAVA @MattNachtrab 🤡😁
‘Rare’ criminal charges for data manipulation in #SAVA case send a ‘powerful message’: lawyers retractionwatch.com/2024/07/…
